UNAIDS welcomes US decision to keep funding life-saving HIV treatment - UN News

UNAIDS welcomes US decision to keep funding life-saving HIV treatment  UN News

A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection  SciTechDaily

Monthly HIV injection could free patients from gruelling drug regimen - Nature

Monthly HIV injection could free patients from gruelling drug regimen  Nature

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization (WHO)

Some children who start antiretrovirals very early may control HIV after stopping treatment - Aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment  Aidsmap

HIV positive sperm bank launched in New Zealand - News-Medical

HIV positive sperm bank launched in New Zealand  News-Medical

Merck's HIV treatment meets main goal in two late-stage studies - Reuters

Merck's HIV treatment meets main goal in two late-stage studies  Reuters

Excision’s EBT-101 Demonstrates Safety in Clinical Trial But Does Not Cure HIV - CRISPR Medicine ...

Excision’s EBT-101 Demonstrates Safety in Clinical Trial But Does Not Cure HIV  CRISPR Medicine News

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - Quartz

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day  Quartz

HIV services in Ukraine resilient but starting to feel the strain - Aidsmap

HIV services in Ukraine resilient but starting to feel the strain  Aidsmap

Will post-treatment controllers guide us towards an HIV cure? - Aidsmap

Will post-treatment controllers guide us towards an HIV cure?  Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected - Aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected  Aidsmap

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment - Aid...

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment  Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - Aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective - Aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective  Aidsmap

London patient in long-term HIV remission after stem cell transplant - Aidsmap

London patient in long-term HIV remission after stem cell transplant  Aidsmap

Islatravir plus doravirine remains effective at 96 weeks - Aidsmap

Islatravir plus doravirine remains effective at 96 weeks  Aidsmap

Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries  Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? - Aidsmap

What are the roles of TAF and integrase inhibitors in weight gain?  Aidsmap

Long-acting injectable treatment maintains viral suppression - Aidsmap

Long-acting injectable treatment maintains viral suppression  Aidsmap

Broadly neutralising antibodies may be partners for long-acting antiretrovirals - Aidsmap

Broadly neutralising antibodies may be partners for long-acting antiretrovirals  Aidsmap

Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey  Aidsmap

HIV infections lowered by 30% in universal testing and treatment study - Aidsmap

HIV infections lowered by 30% in universal testing and treatment study  Aidsmap

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy  Aidsmap

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options - Fierce ...

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options  Fierce Pharma

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  Aidsmap

South Africa: dropping out of HIV care is deadly - Aidsmap

South Africa: dropping out of HIV care is deadly  Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - Aidsmap

Reappearance of HIV in "Mississippi Baby" poses questions for early treatment  Aidsmap

Trump order set to halt supply of HIV, malaria drugs to poor countries as part of aid freeze, sou...

Trump order set to halt supply of HIV, malaria drugs to poor countries as part of aid freeze, sources say  nypost.com

Dolutegravir recommended for all in new World Health Organization guidelines - Aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines  Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV - Aidsmap

Oral six-month treatment for MDR-TB is safe and effective in people with HIV  Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe  Aidsmap

Are CD4 counts still useful in the 'treat all' era? - Aidsmap

Are CD4 counts still useful in the 'treat all' era?  Aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  Aidsmap

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir...

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label,  The Lancet

Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment  The Verge

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - Aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries  Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa - Aidsmap

ADVANCE trial shows dolutegravir is highly effective in South Africa  Aidsmap

Fierce JPM Week: Vir CEO Scangos on competing in the COVID antibody space—and life beyond the pan...

Fierce JPM Week: Vir CEO Scangos on competing in the COVID antibody space—and life beyond the pandemic  Fierce Biotech

Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis  Frontier Myanmar

Touting better HIV treatment, Toronto service organization closing after 42 years - CBC

Touting better HIV treatment, Toronto service organization closing after 42 years  CBC

Asian people with HIV gain weight after starting treatment at similar rate to other ethnic groups...

Asian people with HIV gain weight after starting treatment at similar rate to other ethnic groups (Mandarin)  Aidsmap

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs ...

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs (Mandarin)  Aidsmap

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - Aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin)  Aidsmap